| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |